Hologic Statistics
Total Valuation
Hologic has a market cap or net worth of $17.22 billion. The enterprise value is $17.61 billion.
| Market Cap | 17.22B |
| Enterprise Value | 17.61B |
Important Dates
The next estimated earnings date is Monday, July 29, 2024, after market close.
| Earnings Date | Jul 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Hologic has 233.38 million shares outstanding. The number of shares has decreased by -4.90% in one year.
| Shares Outstanding | 233.38M |
| Shares Change (YoY) | -4.90% |
| Shares Change (QoQ) | -1.10% |
| Owned by Insiders (%) | 0.72% |
| Owned by Institutions (%) | 99.24% |
| Float | 230.14M |
Valuation Ratios
The trailing PE ratio is 37.84 and the forward PE ratio is 17.19. Hologic's PEG ratio is 1.45.
| PE Ratio | 37.84 |
| Forward PE | 17.19 |
| PS Ratio | 4.35 |
| Forward PS | 4.10 |
| PB Ratio | 3.55 |
| P/FCF Ratio | 18.15 |
| PEG Ratio | 1.45 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.72, with an EV/FCF ratio of 18.56.
| EV / Earnings | 37.74 |
| EV / Sales | 4.45 |
| EV / EBITDA | 17.72 |
| EV / EBIT | 26.10 |
| EV / FCF | 18.56 |
Financial Position
The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.53.
| Current Ratio | 3.97 |
| Quick Ratio | 2.96 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 2.59 |
| Debt / FCF | 2.71 |
| Interest Coverage | 5.91 |
Financial Efficiency
Return on equity (ROE) is 9.50% and return on invested capital (ROIC) is 6.08%.
| Return on Equity (ROE) | 9.50% |
| Return on Assets (ROA) | 5.20% |
| Return on Capital (ROIC) | 6.08% |
| Revenue Per Employee | $566,609 |
| Profits Per Employee | $66,738 |
| Employee Count | 6,990 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.97 |
Taxes
In the past 12 months, Hologic has paid $94.00 million in taxes.
| Income Tax | 94.00M |
| Effective Tax Rate | 16.77% |
Stock Price Statistics
The stock price has decreased by -6.48% in the last 52 weeks. The beta is 1.01, so Hologic's price volatility has been similar to the market average.
| Beta (1Y) | 1.01 |
| 52-Week Price Change | -6.48% |
| 50-Day Moving Average | 75.83 |
| 200-Day Moving Average | 72.97 |
| Relative Strength Index (RSI) | 42.50 |
| Average Volume (30 Days) | 1,523,871 |
Short Selling Information
The latest short interest is 4.52 million, so 1.94% of the outstanding shares have been sold short.
| Short Interest | 4.52M |
| Short Previous Month | 4.58M |
| Short % of Shares Out | 1.94% |
| Short % of Float | 1.96% |
| Short Ratio (days to cover) | 3.18 |
Income Statement
In the last 12 months, Hologic had revenue of $3.96 billion and earned $466.50 million in profits. Earnings per share was $1.95.
| Revenue | 3.96B |
| Gross Profit | 1.98B |
| Operating Income | 541.70M |
| Pretax Income | 560.50M |
| Net Income | 466.50M |
| EBITDA | 993.40M |
| EBIT | 674.60M |
| Earnings Per Share (EPS) | $1.95 |
Balance Sheet
The company has $2.18 billion in cash and $2.57 billion in debt, giving a net cash position of -$388.50 million or -$1.66 per share.
| Cash & Cash Equivalents | 2.18B |
| Total Debt | 2.57B |
| Net Cash | -388.50M |
| Net Cash Per Share | -$1.66 |
| Equity / Book Value | 4.84B |
| Book Value Per Share | 20.76 |
| Working Capital | 2.83B |
Cash Flow
In the last 12 months, operating cash flow was $1.10 billion and capital expenditures -$155.00 million, giving a free cash flow of $948.90 million.
| Operating Cash Flow | 1.10B |
| Capital Expenditures | -155.00M |
| Free Cash Flow | 948.90M |
| FCF Per Share | $4.02 |
Margins
Gross margin is 49.93%, with operating and profit margins of 13.68% and 11.78%.
| Gross Margin | 49.93% |
| Operating Margin | 13.68% |
| Pretax Margin | 14.15% |
| Profit Margin | 11.78% |
| EBITDA Margin | 25.08% |
| EBIT Margin | 17.03% |
| FCF Margin | 23.96% |
Dividends & Yields
Hologic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.90% |
| Shareholder Yield | 4.90% |
| Earnings Yield | 2.71% |
| FCF Yield | 5.51% |
Analyst Forecast
The average price target for Hologic is $86.45, which is 17.17% higher than the current price. The consensus rating is "Buy".
| Price Target | $86.45 |
| Price Target Difference | 17.17% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 5.00% |
| EPS Growth Forecast (5Y) | 25.18% |
Stock Splits
The last stock split was on April 3, 2008. It was a forward split with a ratio of 2:1.
| Last Split Date | Apr 3, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Hologic has an Altman Z-Score of 4.17 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.17 |
| Piotroski F-Score | 7 |